Literature DB >> 21401604

Protection against advanced glycation end products and oxidative stress during the development of diabetic keratopathy by KIOM-79.

Junghyun Kim1, Chan-Sik Kim, Hyojun Kim, Il-Ha Jeong, Eunjin Sohn, Jin Sook Kim.   

Abstract

OBJECTIVES: KIOM-79 is a mixture of 80% ethanol extracts of parched Puerariae radix, gingered Magnoliae cortex, Glycyrrhizae radix and Euphorbiae radix. The preventive effect of KIOM-79 on the development of diabetic keratopathy has been investigated.
METHODS: Seven-week-old male Zucker diabetic fatty (ZDF) rats were treated with KIOM-79 (50 mg/kg body weight) once a day orally for 13 weeks. The thickness of the cornea was measured and the extent of corneal cell death was detected by a terminal deoxynucleotidyl transferase dUTP nick-end labelling assay. The expression of advanced glycation end products (AGEs), 8-hydroxydeoxyguanosine, nuclear factor-kappaB (NF-κB), Bax and Bcl-2 were evaluated in corneal tissues. KEY
FINDINGS: The administration of KIOM-79 prevented corneal oedema and apoptotic cell death of corneal cells. The accumulation of AGE in corneal tissues was reduced in ZDF rats treated with KIOM-79. Moreover, KIOM-79 attenuated oxidative DNA damage, NF-κB activation and Bax overexpression in the cornea.
CONCLUSIONS: The results suggested that KIOM-79 exhibited corneal protective properties by not only reducing oxidative stress but inhibiting the AGEs/NF-κB downstream signal pathway during the development of diabetic keratopathy.
© 2011 The Authors. JPP © 2011 Royal Pharmaceutical Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21401604     DOI: 10.1111/j.2042-7158.2010.01206.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  7 in total

1.  Advanced glycation end products delay corneal epithelial wound healing through reactive oxygen species generation.

Authors:  Long Shi; Hongmei Chen; Xiaoming Yu; Xinyi Wu
Journal:  Mol Cell Biochem       Date:  2013-08-18       Impact factor: 3.396

2.  Diabetes inhibits corneal epithelial cell migration and tight junction formation in mice and human via increasing ROS and impairing Akt signaling.

Authors:  Qi-Wei Jiang; Denis Kaili; Jonaye Freeman; Chong-Yang Lei; Bing-Chuan Geng; Tao Tan; Jian-Feng He; Zhi Shi; Jian-Jie Ma; Yan-Hong Luo; Heather Chandler; Hua Zhu
Journal:  Acta Pharmacol Sin       Date:  2019-03-13       Impact factor: 6.150

3.  Protective effect of aldehyde dehydrogenase 2 against rat corneal dysfunction caused by streptozotocin-induced type I diabetes.

Authors:  Pan Long; Mengshan He; Xi Zhang; Tao Luo; Yang Shen; Heng Liu; Wei Jiang; Fei Han; Yonghe Hu
Journal:  Exp Biol Med (Maywood)       Date:  2021-05-08

Review 4.  A systematic review on the impact of diabetes mellitus on the ocular surface.

Authors:  K Co Shih; K S-L Lam; L Tong
Journal:  Nutr Diabetes       Date:  2017-03-20       Impact factor: 5.097

Review 5.  Diabetic Corneal Neuropathy: Pathogenic Mechanisms and Therapeutic Strategies.

Authors:  Ting Zhou; Allie Lee; Amy Cheuk Yin Lo; Jeremy Sze Wai John Kwok
Journal:  Front Pharmacol       Date:  2022-02-23       Impact factor: 5.810

6.  Advanced glycation end products induce human corneal epithelial cells apoptosis through generation of reactive oxygen species and activation of JNK and p38 MAPK pathways.

Authors:  Long Shi; Xiaoming Yu; Hongling Yang; Xinyi Wu
Journal:  PLoS One       Date:  2013-06-12       Impact factor: 3.240

7.  Diabetic and non-diabetic human cornea and tear γ-glutamyl transpeptidase activity.

Authors:  Jordan M Burnham; Monali Sakhalkar; Marlyn P Langford; Chanping Liang; Thomas B Redens; Sushil K Jain
Journal:  Clin Ophthalmol       Date:  2013-01-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.